| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |